May 3 |
Perspective Therapeutics to Participate at Upcoming May Investor Conferences
|
May 3 |
Lantheus Holdings Inc (LNTH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
|
May 2 |
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
|
Apr 30 |
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
|
Apr 8 |
Perspective Therapeutics to Participate at Upcoming April Investor Conferences
|
Mar 30 |
Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results
|
Mar 28 |
Perspective Therapeutics GAAP EPS of -$0.14, revenue of $1.43M
|
Mar 28 |
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
|
Mar 19 |
Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal
|
Mar 18 |
Perspective Therapeutics partners with Bristol Myers for its metastatic melanoma treatment study
|